Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan

Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
Chien-Hsuan ChouWen-Chien Ko

Abstract

An increased incidence of vancomycin-resistant enterococcal bloodstream infections (VRE BSI) in the United States has been noted in recent years. There were a few reports of VRE BSI in Taiwan. This study is intended to show the epidemiology, clinical features and outcomes of VRE BSI at a medical center in southern Taiwan. A retrospective study was conducted from January 1, 2005 to December 31, 2010. All patients with VRE BSI episodes were identified and their medical records were reviewed. A total of 69 episodes of VRE BSI were identified in the study period. The incidence rate increased from 0.01 episodes of VRE BSI/1000 patient-days in 2005 to 0.07 episodes of VRE BSI/1000 patient-days in 2010. The 30-day mortality rate was 52.17% for all patients with VRE BSI. The mortality rate of patients who received in vitro active and inactive antimicrobial therapy for VRE BSI was 40% and 100%, respectively (p < 0.001). Factors associated with mortality were shock [odds ratio (OR) 24.4, 95% confidence interval (CI) 3.6-163.2, p = 0.001], renal failure (OR 90.9, 95% CI 1.9-4404.3, p = 0.02), and underlying liver cirrhosis (OR 12.4, 95% CI 1.2-125.8, p = 0.03). Use of linezolid for VRE BSI showed a trend for lower 30-day mortality than da...Continue Reading

References

Jul 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G A LosonskyE W Lewis
Mar 9, 2000·The New England Journal of Medicine·B E Murray
Mar 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J M GarbuttL M Mundy
Apr 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D E LowR N Jones
Mar 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas P LodiseMichael J Rybak
Mar 15, 2002·The New England Journal of Medicine·Inmaculada A HerreroRobin Patel
Sep 27, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Cassandra D Salgado, Barry M Farr
Nov 5, 2003·Diagnostic Microbiology and Infectious Disease·Kathleen A RuggeroJohn P Quinn
Jul 12, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carlos A DiazGranadosJohn A Jernigan
May 20, 2006·Scandinavian Journal of Infectious Diseases·N KvirikadzeK Singh
Oct 19, 2006·International Journal of Antimicrobial Agents·Diane M AnastasiouJeff D Alder
Oct 13, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·G GhanemI Raad
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kristine Mace ErlandsonMark E Rupp
Oct 14, 2008·Expert Review of Anti-infective Therapy·Cesar A Arias, Barbara E Murray
May 9, 2009·The Journal of Antimicrobial Chemotherapy·Vidya MaveRodrigo Hasbun

❮ Previous
Next ❯

Citations

Jul 31, 2013·International Journal of Clinical Pharmacy·Bhavarth S ShuklaLilian Abbo
Feb 25, 2015·Infectious Diseases and Therapy·Jeffrey M Rybak, Karrine Roberts
Aug 1, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Y-C ChuangS-C Chang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
C C LaiP R Hsueh
The New England Journal of Medicine
Vance G FowlerS. aureus Endocarditis and Bacteremia Study Group
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Alicia I HidronParticipating National Healthcare Safety Network Facilities
© 2021 Meta ULC. All rights reserved